Treatment of Atherosclerotic Renovascular Disease

被引:7
|
作者
Bittl, John A. [1 ]
机构
[1] Munroe Reg Med Ctr, Ocala, FL USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 370卷 / 01期
关键词
RENAL-ARTERY STENOSIS; HYPERTENSION;
D O I
10.1056/NEJMe1313423
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
If the treatment of renal-artery stenoses can improve blood pressure and renal function,(1) why have clinical trials of renal-artery stenting failed to reduce the rates of renal and cardiovascular events?(2)-(4) The answer is found by examining the design and results of the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial, now reported in the Journal,(4) which concludes that implanting stents for moderately severe obstructive renovascular disease is no better than medical therapy alone in preventing the primary end point of death from cardiovascular or renal causes, myocardial infarction, stroke, hospitalization for heart failure, progression of renal failure, or the ...
引用
收藏
页码:78 / 79
页数:2
相关论文
共 50 条
  • [41] Peristenotic Collateral Circulation in Atherosclerotic Renovascular Disease Association With Kidney Function and Response to Treatment
    Afarideh, Mohsen
    Zhang, Xin
    Ferguson, Christopher M.
    Glockner, James F.
    Lerman, Amir
    Textor, Stephen C.
    Lerman, Lilach O.
    HYPERTENSION, 2020, 76 (02) : 497 - 505
  • [42] Clinical utility of the resistive index in atherosclerotic renovascular disease
    Crutchley, Teresa A.
    Pearce, Jeffrey D.
    Craven, Timothy E.
    Stafford, Jeanette M.
    Edwards, Matthew S.
    Hansen, Kimberley J.
    JOURNAL OF VASCULAR SURGERY, 2009, 49 (01) : 148 - 155
  • [43] The impact of atherosclerotic renovascular disease on diabetic renal failure
    Nicholls, AJ
    DIABETIC MEDICINE, 2002, 19 (11) : 889 - 894
  • [44] Revascularization in atherosclerotic renovascular disease: Problems beyond the obstruction
    Chade, A. R.
    KIDNEY INTERNATIONAL, 2006, 70 (05) : 830 - 832
  • [45] ACE gene polymorphism and survival in atherosclerotic renovascular disease
    Losito, A
    Parente, B
    Cao, PG
    Jeffery, S
    Afzal, AR
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) : 211 - 215
  • [46] To Stent or Not to Stent? Update on Revascularization for Atherosclerotic Renovascular Disease
    Noory, Elias
    Sritharan, Kaji
    Zeller, Thomas
    CURRENT HYPERTENSION REPORTS, 2016, 18 (06)
  • [47] Stenting and cell technologies in the treatment of atherosclerotic renovascular hypertension
    Kharlamov, A. N.
    Gabinsky, Ya. L.
    Freydlina, M. S.
    Bos, E. K.
    Naydanova, T. A.
    Chernyshev, S. D.
    Fadin, B. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (04): : 83 - 88
  • [48] Chlamydia pneumoniae seropositivity and systemic and renovascular atherosclerotic disease
    van der Ven, AJAM
    Hommels, MJ
    Kroon, AA
    Kessels, A
    Flobbe, K
    van Engelshoven, J
    Bruggeman, CA
    de Leeuw, PW
    ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (07) : 786 - 790
  • [49] Atherosclerotic renovascular disease and cardiovascular risk: new concepts
    Januszewicz, Andrzej
    Januszewicz, Magdalena
    Prejbisz, Aleksander
    Dobrowolski, Piotr
    Persu, Alexandre
    Kreutz, Reinhold
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2022, 132 (12):
  • [50] Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease
    Yu, Mark Shipeng
    Folt, David A.
    Drummond, Christopher A.
    Haller, Steven T.
    Cooper, Emily L.
    Brewster, Pamela
    Evans, Kaleigh L.
    Cooper, Christopher J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (12) : 1 - 9